A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management
A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management
复制标题
DOI：
10.1093/asj/sjz312
复制
发表时间：
2020-09-01
影响因子：
2.9
通讯作者：
Kosenko, David E.
中科院分区：
文献类型：
--
作者：
Goodman, Greg J.;Magnusson, Mark R.;Kosenko, David E.
背景：透明质酸填充剂具有令人满意的安全性。但不良反应确实会发生，很少血管内注射可能导致失明。目前还没有国际公认的共识，对失明的预防或管理透明质酸filler.Objectives：作者试图提供指导，如何尽量减少风险和优化管理这种罕见的，但灾难性的不良反应。研究方法：来自多个学科的美容注射剂专家组成的多国小组召开会议，审查当前的最佳实践，并制定最新的共识建议，以预防和床边干预，如果在美容注射透明质酸填充剂后发生视力丧失。协商一致小组提出了具体建议，重点是同意过程、预防、结论：虽然由于血管内透明质酸填充剂注射导致的视力丧失是罕见的，但患者和医生都必须意识到这一风险。在本文中，作者描述了可用于降低风险的方法和技术，并记录了临床医生发现自己处于这种情况时的初步管理建议。
Background: Hyaluronic acid fillers have a satisfactory safety profile. However, adverse reactions do occur, and rarely intravascular injection may lead to blindness. Currently there is no internationally recognized consensus on the prevention or management of blindness from hyaluronic acid filler.Objectives: The authors sought to give guidance on how to minimize the risk and optimize the management of this rare but catastrophic adverse reaction. Methods: A multinational group of experts in cosmetic injectables from multiple disciplines convened to review current best practice and develop updated consensus recommendations for prevention and bedside intervention if visual loss occurs after cosmetic injection of hyaluronic acid filler.Results: The consensus group provided specific recommendations focusing on the consenting process, prevention, and early management of visual impairment related to intravascular hyaluronic acid filler injection.Conclusions: Although visual loss due to filler injections is rare, it is important that both patient and physician be aware of this risk. In this paper the authors describe methods and techniques available to reduce the risk and also document suggested initial management should a clinician find themselves in this situation.